Heart failure leads to altered b2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K
ATPase microdomain
ATPase microdomain
File(s)CVR-2017-375_R1.pdf (19.28 MB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Aims: Cyclic adenosine monophosphate (cAMP) regulates cardiac excitation-contraction coupling by acting in microdomains associated with sarcolemmal ion channels. However, local real time cAMP dynamics in such microdomains has not been visualized before. We sought to directly monitor cAMP in a microdomain formed around sodium-potassium ATPase (NKA) in healthy and failing cardiomyocytes and to better understand alterations of cAMP compartmentation in heart failure. Methods and Results: A novel Förster resonance energy transfer (FRET)-based biosensor termed PLM-Epac1 was developed by fusing a highly sensitive cAMP sensor Epac1-camps to the C-terminus of phospholemman (PLM). Live cell imaging in PLM-Epac1 and Epac1-camps expressing adult rat ventricular myocytes revealed extensive regulation of NKA/PLM microdomain associated cAMP levels by β2-adrenoceptors (β2-ARs). Local cAMP pools stimulated by these receptors were tightly controlled by phosphodiesterase (PDE) type 3. In chronic heart failure following myocardial infarction, dramatic reduction of the microdomain-specific β2-AR/cAMP signals and β2-AR dependent PLM phosphorylation was accompanied by a pronounced loss of local PDE3 and an increase in PDE2 effects. Conclusions: NKA/PLM complex forms a distinct cAMP microdomain which is directly regulated by β2-ARs and is under predominant control by PDE3. In heart failure, local changes in PDE repertoire result in blunted β2-AR signaling to cAMP in the vicinity of PLM.
Date Issued
2018-08-27
Date Acceptance
2018-08-23
Citation
Cardiovascular Research, 2018, 115 (3), pp.546-555
ISSN
1755-3245
Publisher
Oxford University Press (OUP)
Start Page
546
End Page
555
Journal / Book Title
Cardiovascular Research
Volume
115
Issue
3
Copyright Statement
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
Sponsor
Medical Research Council (MRC)
British Heart Foundation
British Heart Foundation
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30165515
PII: 5079901
Grant Number
MR/L006855/1
RG/12/18/30088
RG/17/13/33173
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
cAMP
Phospholemman
Phosphodiesterase
FRET
Heart failure
DEPENDENT PROTEIN-KINASE
CARDIAC MYOCYTES
VENTRICULAR MYOCYTES
FAILING HEARTS
NA+ TRANSPORT
POWER OUTPUT
PHOSPHORYLATION
EXPRESSION
CONTRACTILITY
STIMULATION
FRET
Heart failure
Phosphodiesterase
Phospholemman
cAMP
Cardiovascular System & Hematology
1102 Cardiorespiratory Medicine and Haematology
Publication Status
Published
Coverage Spatial
England
Article Number
cvy221
Date Publish Online
2018-08-27